Paul Castillo Caro, M.D.
Clinical Assistant Professor
About Paul Castillo Caro
The research efforts of Dr. Castillo are supported by STOP Children’s Cancer.
Teaching Profile
Courses Taught
2018
MDC7400 Pediatric Clerkship
2021-2023
GMS6065 Fundamentals of Cancer Biology
Board Certifications
-
PediatricsAmerican Board of Pediatrics
Clinical Profile
Specialties
- Pediatrics
Subspecialties
- Pediatric Hematology-Oncology
Areas of Interest
- Bone marrow transplant
Research Profile
The research efforts of Dr. Castillo are supported by STOP Children’s Cancer.
Publications
2019
Purtscher-like retinopathy: A rare presentation of hematopoietic stem cell transplant-associated thrombotic microangiopathy
Pediatric Transplantation.
23(2)
[DOI] 10.1111/petr.13344.
Grants
Apr 2022
ACTIVE
Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial, with Cross-Over, of Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation
Role: Principal Investigator
Funding: MEDPACE
via ALLOVIR
Apr 2022
ACTIVE
Unlocking CAR T cell efficacy against osteosarcoma using adjuvant RNA vaccine
Role: Principal Investigator
Funding: FL DEPT OF HLTH LIVE LIKE BELLA
Mar 2022
ACTIVE
Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of ALVR105 (Viralym-M) Compared to Placebo for the Prevention of AdV, BKV, CMV, EBV, HHV-6, and JCV Infection and/or Disease, in High-Risk Patients After Allogeneic Hematopoietic Cell Transplant
Role: Principal Investigator
Funding: ICON CLINICAL RESEARCH INC
via ALLOVIR
Aug 2021
ACTIVE
Targeting Primary CNS B cell Lymphoma Unique Antigens with Novel Immunotherapy
Role: Principal Investigator
Funding: AMER BRAIN TUMOR ASSOCIATION
Aug 2018
– Dec 2020
Enhancing T cell adoptive therapy against T cell acute lymphoblastic leukemia
Role: Principal Investigator
Funding: HYUNDAI HOPE ON WHEELS
May 2017
– Jan 2022
A Phase II, Open-label, Non-controlled, Intra-patient Dose-escalation Study to Characterize the Pharmacokinetics After Oral Administration of Eltrombopag in Pediatric Patients With Refractory, Relapsed or Treatment Naive Severe Aplastic Anemia or Recurrent Aplastic Anemia
Role: Principal Investigator
Funding: NOVARTIS PHARMACEUTICALS CORP
Feb 2017
– Feb 2022
Pathogen Identification in Pediatric Hematopoietic Stem Cell Transplant Patients with Suspected Lower Respiratory Tract Infection
Role: Principal Investigator
Funding: CHILDRENS HOSP LOS ANGELES
via NATL INST OF HLTH NIAID
Feb 2017
– Feb 2022
Pathogen Identification in Pediatric Hematopoietic Stem Cell Transplant Patients with Suspected Lower Respiratory Tract Infection
Role: Principal Investigator
Funding: CHILDRENS HOSP LOS ANGELES
Sep 2015
– Dec 2016
214 Fund Retrospective Study of Pediatric Aplastic Anemia
Role: Principal Investigator
Funding: CHILDRENS HOSPITAL CORPORATION
Sep 2013
– Jun 2016
Minimizing Leukemia Relapse: A Phase I, Dose Escalation Study of Decitabine in High Risk Pediatric and Young Adult Leukemia Post Allogeneic Stem Cell Transplantation
Role: Principal Investigator
Funding: HYUNDAI HOPE ON WHEELS
Education
Fellowship – Pediatric Stem Cell Transplantation
2015
·
Texas Children's Hospital
Fellowship – Pediatric Hematology/Oncology
2014
·
Texas Children's Hospital
Residency – Pediatrics
2011
·
Riley Hospital for Children
Medical Degree
2005
·
Universidad Peruana Cayetano Heredia
Contact Details
Phones:
- Business:
- (352) 273-9120
Emails:
- Business:
- castillopa@ufl.edu
Addresses:
- Business Mailing:
-
PO BOX 100296
DEPT OF PEDIATRICS
GAINESVILLE FL 326100296 - Business Street:
-
HD-212 A
1600 SW ARCHER RD
Gainesville FL 32610